Cue Biopharma, Inc.
SEC CIK 1645460 · CUE · last insider filing 2026-06-11
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Camardo Daniel A. | Director | filed 2026 - 2026 |
| Lin Shao-Lee | Director · Chief Executive Officer | filed 2026 - 2026 |
| Meehan Viola Mong | Director | filed 2026 - 2026 |
| Church Jill Marie | Director | filed 2025 - 2026 |
| Kiener Peter A | Director | filed 2017 - 2026 |
| Morich Frank | Director | filed 2018 - 2026 |
| Verheyen Patrick | Director | filed 2023 - 2026 |
| Garzone Pamela | Director | filed 2023 - 2026 |
| Sarraf Pasha | Director | filed 2025 - 2026 |
| Azam Usman | Director · CHIEF EXECUTIVE OFFICER | filed 2025 - 2025 |
| Passeri Daniel R | Director · CHIEF EXECUTIVE OFFICER | filed 2017 - 2025 |
| Driscoll Frederick W | Director | filed 2018 - 2025 |
| Fox Michael J | Director | filed 2024 - 2024 |
| Howson Tamar D | Director | filed 2020 - 2023 |
| Fletcher Aaron G.L. | Director | filed 2019 - 2023 |
| Gray Cameron | Director | filed 2017 - 2022 |
| Simon Barry J. | Director | filed 2017 - 2021 |
| Mcknight Steven L | Director | filed 2017 - 2020 |
| Marlett Christopher A | Director | filed 2017 - 2020 |
| Digiandomenico Anthony | Director | filed 2017 - 2019 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Ray Sumita | Chief Legal Compliance Officer | filed 2026 - 2026 |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | filed 2026 - 2026 |
| Sandercock Colin | SVP, General Counsel and Sec | filed 2017 - 2026 |
| Warren Lucinda | CHIEF BUSINESS OFFICER | filed 2024 - 2026 |
| Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | filed 2024 - 2026 |
| Millar Kerri-Ann | VP-Finance | filed 2018 - 2025 |
| Levisetti Matteo | Chief Medical Officer | filed 2023 - 2025 |
| Suri Anish | President and CSO | filed 2018 - 2024 |
| Nasshorn Patricia | Chief Business Officer | filed 2022 - 2023 |
| Pienta Kenneth | Chief Medical Officer | filed 2017 - 2022 |
| Mancilla Bethany | SVP and Chief Business Officer | filed 2018 - 2019 |
| Chaparro Rodolfo | EVP, Head of Immunology | filed 2017 - 2018 |
| Seidel Ronald D. III | EVP, Head of R&D | filed 2017 - 2018 |
| Schuman Gary Alan | Interim CFO | filed 2017 - 2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.